Onderneming NeuroScientific Biopharmaceuticals Limited
Aandelen
NSB
AU0000012973
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,047 AUD | -2,08% | -9,62% | +6,82% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Simon Scott
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-22 |
Dougal Thring
COO | Chief Operating Officer | - | 31-03-21 |
Anton Uvarov
BRD | Director/Board Member | - | 29-09-17 |
- | - | ||
Corporate Secretary | - | 06/02 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anton Uvarov
BRD | Director/Board Member | - | 29-09-17 |
Chairman | - | 17/11 | |
Tony Keating
BRD | Director/Board Member | - | 05/12 |
Clarke Barlow
BRD | Director/Board Member | 43 | 17/11 |
Linda Friedland
BRD | Director/Board Member | - | 18-10-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 144 604 870 | 94 222 747 ( 65,16 %) | 0 | 65,16 % |
Bedrijfsgegevens
Neuroscientific Biopharmaceuticals Ltd.
85 Forrest Street Suite 5
6011, Cottesloe
+61 8 6382 1805
http://www.neuroscientific.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,82% | 4,6 mln. | |
+20,27% | 46,81 mld. | |
-1,03% | 41,37 mld. | |
+47,07% | 41,29 mld. | |
-3,52% | 28,87 mld. | |
+11,65% | 26,06 mld. | |
-19,60% | 19,13 mld. | |
+32,76% | 12,39 mld. | |
+0,22% | 12,08 mld. | |
-0,30% | 11,96 mld. |